BioPhytMol: A drug discovery community resource on anti-mycobacterial phytomolecules and plant extracts

Photonic Sensors

Volumn 6, Issue 1, 2014, Pages

  Sharma, Arun ^a   Dutta, Prasun ^a   Sharma, Maneesh ^d   Rajput, Neeraj Kumar ^a   Dodiya, Bhavna ^b   Georrge, John J ^c,e   Kholia, Trupti ^c   Bhardwaj, Anshu ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

^b M S UNIVERSITY OF BARODA   (India)

^c Christ College   (India)

^d UNIVERSITY OF DELHI   (India)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Anti mycobacterial; Anti TB; Anti tubercular; BioPhytMol; Crowdsourcing; Drug discovery; TB; Tuberculosis

Indexed keywords

BIOACTIVITY; CHEMICAL ANALYSIS; CROWDSOURCING; SEARCH ENGINES; TERBIUM;

ANTI TUBERCULARS; ANTI-MYCOBACTERIAL; BIOPHYTMOL; DRUG DISCOVERY; TUBERCULOSIS;

PLANT EXTRACTS;

EID: 84919779357     PISSN: 16749251     EISSN: 21907439     Source Type: Journal    
DOI: 10.1186/s13321-014-0046-2     Document Type: Article

References (39)

1. Global Tuberculosis report. In [http://www.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf]
2. Zumla A, Nahid P, Cole ST: Advances in the development of new tuberculosis drugs and treatment regimens.Nat Rev Drug Discov 2013, 12:388–404.
3. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J: Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.Lancet 2010, 375:1830–1843.
4. Cohen J: Infectious disease. Approval of novel TB drug celebrated--with restraint.Science 2013, 339:130.
5. Ngo LT, Okogun JI, Folk WR: 21st century natural product research and drug development and traditional medicines.Nat Prod Rep 2013, 30:584–592.
6. Palomino JC, Ramos DF, da Silva PA: New anti-tuberculosis drugs: strategies, sources and new molecules.Curr Med Chem 2009, 16:1898–1904.
7. Butler MS, Buss AD: Natural products–the future scaffolds for novel antibiotics?Biochem Pharmacol 2006, 71:919–929.
8. Jachak SM, Saklani A: Challenges and opportunities in drug discovery from plants.Curr Sci 2007, 92:1251–1257.
9. Lahlou M: The success of natural products in drug discovery.Pharmacol Pharmacy 2013, 4:17–31.
10. Newman DJ, Cragg GM: Natural products as sources of new drugs over the 30 years from 1981 to 2010.J Nat Prod 2012, 75:311–335.
11. Garcia A, Bocanegra-Garcia V, Palma-Nicolas JP, Rivera G: Recent advances in antitubercular natural products.Eur J Med Chem 2012, 49:1–23.
12. Rogoza LN: Anti-tubercular activity of natural products: Recent developments. In Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry. Edited by Tiwari VK. Trivandrum, Kerala, India: Research Signpost; 2011:103–120.
13. Ekins S, Freundlich JS, Choi I, Sarker M, Talcott C: Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.Trends Microbiol 2011, 19:65–74.
14. Open Source Drug Discovery Resources. In [http://www.osdd.net/research-development/publications-and-presentations]
15. Gu J, Gui Y, Chen L, Yuan G, Lu HZ, Xu X: Use of natural products as chemical library for drug discovery and network pharmacology.PLoS One 2013, 8:e62839.
16. Valli M, dos Santos RN, Figueira LD, Nakajima CH, Castro-Gamboa I, Andricopulo AD, Bolzani VS: Development of a natural products database from the biodiversity of Brazil.J Nat Prod 2013, 76:439–444.
17. Ntie-Kang F, Mbah JA, Mbaze LM, Lifongo LL, Scharfe M, Hanna JN, Cho-Ngwa F, Onguene PA, Owono Owono LC, Megnassan E, Sippl W, Efange SM: CamMedNP: building the Cameroonian 3D structural natural products database for virtual screening.BMC Complement Altern Med 2013, 13:88.
18. Dunkel M, Fullbeck M, Neumann S, Preissner R: SuperNatural: a searchable database of available natural compounds.Nucleic Acids Res 2006, 34:D678–D683.
19. Ye H, Ye L, Kang H, Zhang D, Tao L, Tang K, Liu X, Zhu R, Liu Q, Chen YZ, Li Y, Cao Z: HIT: linking herbal active ingredients to targets.Nucleic Acids Res 2011, 39:D1055–D1059.
20. Mangal M, Sagar P, Singh H, Raghava GP, Agarwal SM: NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target database.Nucleic Acids Res 2013, 41:D1124–D1129.
21. Chen CY: TCM Database@Taiwan: the world’s largest traditional Chinese medicine database for drug screening in silico.PLoS One 2011, 6:e15939.
22. Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T: TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis.Nucleic Acids Res 2013, 41:D1089–D1095.
23. Kang H, Tang K, Liu Q, Sun Y, Huang Q, Zhu R, Gao J, Zhang D, Huang C, Cao Z: HIM-herbal ingredients in-vivo metabolism database.J Cheminform 2013, 5:28.
24. Ntie-Kang F, Zofou D, Babiaka SB, Meudom R, Scharfe M, Lifongo LL, Mbah JA, Mbaze LM, Sippl W, Efange SM: AfroDb: A select highly potent and diverse natural product library from African Medicinal Plants.PLoS One 2013, 8:e78085.
25. Ntie-Kang F, Onguene PA, Scharfe M, Owono Owono LC, Megnassan E, Mbaze LM, Sippl W, Efange SMN: ConMedNP: a natural product library from Central African medicinal plants for drug discovery.RSC Adv 2014, 4:409–419.
26. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Drug Deliv Rev 2001, 46:3–26.
27. Csizmadia F: JChem: Java applets and modules supporting chemical database handling from web browsers.J Chem Inf Comput Sci 2000, 40:323–324.
28. Liu K, Feng J, Young SS: PowerMV: a software environment for molecular viewing, descriptor generation, data analysis and hit evaluation.J Chem Inf Model 2005, 45:515–522.
29. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA: Circos: an information aesthetic for comparative genomics.Genome Res 2009, 19:1639–1645.
30. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD: Molecular properties that influence the oral bioavailability of drug candidates.J Med Chem 2002, 45:2615–2623.
31. Congreve M, Carr R, Murray C, Jhoti H: A ‘rule of three’ for fragment-based lead discovery?Drug Discov Today 2003, 8:876–877.
32. Kumar R, Singh G, Swami G, Krishan P, Kumari P, Rizvi SI: Nutraceuticals: a boom to medical industry.Res Gate: Pharmaceut Sci 2013, 2:8.
33. Oprea TI: Property distribution of drug-related chemical databases.J Comput Aided Mol Des 2000, 14:251–264.
34. Ghose AK, Viswanadhan VN, Wendoloski JJ: A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.J Comb Chem 1999, 1:55–68.
35. Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL: Quantifying the chemical beauty of drugs.Nat Chem 2012, 4:90–98.
36. Rishton GM: Nonleadlikeness and leadlikeness in biochemical screening.Drug Discov Today 2003, 8:86–96.
37. Ballell L, Bates RH, Young RJ, Alvarez-Gomez D, Alvarez-Ruiz E, Barroso V, Blanco D, Crespo B, Escribano J, Gonzalez R, Lozano S, Huss S, Santos-Villarejo A, Martín-Plaza JJ, Mendoza A, Rebollo-Lopez MJ, Remuiñan-Blanco M, Lavandera JL, Pérez-Herran E, Gamo-Benito FJ, García-Bustos JF, Barros D, Castro JP, Cammack N: Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis.Chem Med Chem 2013, 8:313–321.
38. Martinez-Jimenez F, Papadatos G, Yang L, Wallace IM, Kumar V, Pieper U, Sali A, Brown JR, Overington JP, Marti-Renom MA: Target prediction for an open access set of compounds active against Mycobacterium tuberculosis.PLoS Comput Biol 2013, 9:e1003253.
39. Clark A, Sarker M, Ekins S: New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 20.J Chem Informatics 2014, 6:38.